These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 38401878)

  • 1. Recent advances in 3D bioprinting for cancer research: From precision models to personalized therapies.
    Ruchika ; Bhardwaj N; Yadav SK; Saneja A
    Drug Discov Today; 2024 Apr; 29(4):103924. PubMed ID: 38401878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in 3D Bioprinting for Cancer Biology and Precision Medicine: From Matrix Design to Application.
    Jung M; Ghamrawi S; Du EY; Gooding JJ; Kavallaris M
    Adv Healthc Mater; 2022 Dec; 11(24):e2200690. PubMed ID: 35866252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Advances in 3D Bioprinting for Cancer Modeling and Personalized Medicine.
    Germain N; Dhayer M; Dekiouk S; Marchetti P
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D Bioprinting: An Important Tool for Tumor Microenvironment Research.
    Li Y; Liu J; Xu S; Wang J
    Int J Nanomedicine; 2023; 18():8039-8057. PubMed ID: 38164264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in tumor microenvironment: Applications and challenges of 3D bioprinting.
    Dong Y; Zhou X; Ding Y; Luo Y; Zhao H
    Biochem Biophys Res Commun; 2024 Oct; 730():150339. PubMed ID: 39032359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D bioprinting tumor models mimic the tumor microenvironment for drug screening.
    Mi X; Su Z; Yue X; Ren Y; Yang X; Qiang L; Kong W; Ma Z; Zhang C; Wang J
    Biomater Sci; 2023 May; 11(11):3813-3827. PubMed ID: 37052182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D bioprinting of functional tissue models for personalized drug screening and in vitro disease modeling.
    Ma X; Liu J; Zhu W; Tang M; Lawrence N; Yu C; Gou M; Chen S
    Adv Drug Deliv Rev; 2018 Jul; 132():235-251. PubMed ID: 29935988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D bioprinting of engineered breast cancer constructs for personalized and targeted cancer therapy.
    Sharifi M; Bai Q; Babadaei MMN; Chowdhury F; Hassan M; Taghizadeh A; Derakhshankhah H; Khan S; Hasan A; Falahati M
    J Control Release; 2021 May; 333():91-106. PubMed ID: 33774120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Converging bioprinting and organoids to better recapitulate the tumor microenvironment.
    Wang X; Luo Y; Ma Y; Wang P; Yao R
    Trends Biotechnol; 2024 May; 42(5):648-663. PubMed ID: 38071145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of three-dimensional (3D) bioprinting in anti-cancer therapy.
    Wu BX; Wu Z; Hou YY; Fang ZX; Deng Y; Wu HT; Liu J
    Heliyon; 2023 Oct; 9(10):e20475. PubMed ID: 37800075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioprinting of in vitro tumor models for personalized cancer treatment: a review.
    Mao S; Pang Y; Liu T; Shao Y; He J; Yang H; Mao Y; Sun W
    Biofabrication; 2020 Jul; 12(4):042001. PubMed ID: 32470967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mimicking tumor microenvironment by 3D bioprinting: 3D cancer modeling.
    Shukla P; Yeleswarapu S; Heinrich MA; Prakash J; Pati F
    Biofabrication; 2022 May; 14(3):. PubMed ID: 35512666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enabling personalized implant and controllable biosystem development through 3D printing.
    Nagarajan N; Dupret-Bories A; Karabulut E; Zorlutuna P; Vrana NE
    Biotechnol Adv; 2018; 36(2):521-533. PubMed ID: 29428560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D Bioprinting for Next-Generation Personalized Medicine.
    Lam EHY; Yu F; Zhu S; Wang Z
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancements in Research on Constructing Physiological and Pathological Liver Models and Their Applications Utilizing Bioprinting Technology.
    Ming Z; Tang X; Liu J; Ruan B
    Molecules; 2023 Apr; 28(9):. PubMed ID: 37175094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D bioprinting complex models of cancer.
    Sharma R; Restan Perez M; da Silva VA; Thomsen J; Bhardwaj L; Andrade TAM; Alhussan A; Willerth SM
    Biomater Sci; 2023 May; 11(10):3414-3430. PubMed ID: 37000528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D bioprinting: improving in vitro models of metastasis with heterogeneous tumor microenvironments.
    Albritton JL; Miller JS
    Dis Model Mech; 2017 Jan; 10(1):3-14. PubMed ID: 28067628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emulating Human Tissues and Organs: A Bioprinting Perspective Toward Personalized Medicine.
    Fonseca AC; Melchels FPW; Ferreira MJS; Moxon SR; Potjewyd G; Dargaville TR; Kimber SJ; Domingos M
    Chem Rev; 2020 Oct; 120(19):11128-11174. PubMed ID: 32937071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D bioprinted tumor model: a prompt and convenient platform for overcoming immunotherapy resistance by recapitulating the tumor microenvironment.
    Zhang Z; Chen X; Gao S; Fang X; Ren S
    Cell Oncol (Dordr); 2024 Aug; 47(4):1113-1126. PubMed ID: 38520648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving Bioprinted Volumetric Tumor Microenvironments In Vitro.
    Li J; Parra-Cantu C; Wang Z; Zhang YS
    Trends Cancer; 2020 Sep; 6(9):745-756. PubMed ID: 32680649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.